Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Tackle Zero Based Budgeting And Child Expenses with methods that allocate funds for loved ones without compromising long-term goals.
28,655 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
The Vanguard Health Care ETF has underperformed the broader market by roughly 57 points over five years, yet patient ...
Circle Internet Group posted a stronger-than-expected Q1 2026, triggering a 68% year-to-date gain and a rally that ou...
A lithium-tech company unveils a faster, higher-yield extraction method and is moving into commercial-scale productio...
Rising APRs are transforming solar financing, exposing homeowners to longer paybacks and higher total costs. This rep...
Despite rates rising to 6.75%, demand remains resilient and inventory growth stays modest. Early 2026 data point to h...
ECB board member Isabel Schnabel presses for a digital euro to counter stablecoin risks, signaling tighter regulation...
The chip that turned $10k into nearly $20k this year is drawing attention as AI demand and a few megacap chip firms l...
A Wall Street note imagines a SpaceX IPO delivering about 40% upside, powered by a diversified revenue mix. This repo...
Amazon’s Q1 2026 results show AWS posting rapid growth amid a surge in AI demand. With AI revenue above $15B and a $2...
UBS raises AMD’s target to $670, a sharp upgrade that highlights strong AI-driven data center demand. Traders watch f...
The Magnificent 7 erased $2.3 trillion in market value in June, signaling investors are reassessing AI bets and the t...